Clinical Trial Update: Observational Usage Study of Faslodex in Patients Suffering From Initial Breast Cancer in France

View source ↗

Summary

Observational study evaluating real-world use of Faslodex (fulvestrant) for initial breast cancer in France; study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Faslodex (fulvestrant)

Snippet

Sponsor: AstraZeneca | Conditions: Breast Cancer | Status: COMPLETED